Biopharma R&D

Own your trial budgets, from site contract to invoice

Site budgets from your own benchmarks, every invoice against plan and spend you can forecast, for clinical operations and R&D finance.

Biopharma R&D

Own your trial budgets, from site contract to invoice

Site budgets from your own benchmarks, every invoice against plan and spend you can forecast, for clinical operations and R&D finance.

Biopharma R&D

Own your trial budgets, from site contract to invoice

Site budgets from your own benchmarks, every invoice against plan and spend you can forecast, for clinical operations and R&D finance.

Industry data

Every change reprices the trial. Amendments are the rule, not the exception.

Amendments

3.3

substantial amendments per protocol, on average

Phase III

82%

of Phase III protocols need at least one

Time

260

days from sign-off to the last ethics approval

Tufts CSDD amendment study: Getz KA et al., Therapeutic Innovation & Regulatory Science, 2024; Applied Clinical Trials, December 2023.

Industry data

Every change reprices the trial. Amendments are the rule, not the exception.

Amendments

3.3

substantial amendments per protocol, on average

Phase III

82%

of Phase III protocols need at least one

Time

260

days from sign-off to the last ethics approval

Tufts CSDD amendment study: Getz KA et al., Therapeutic Innovation & Regulatory Science, 2024; Applied Clinical Trials, December 2023.

Industry data

Every change reprices the trial. Amendments are the rule, not the exception.

Amendments

3.3

substantial amendments per protocol, on average

Phase III

82%

of Phase III protocols need at least one

Time

260

days from sign-off to the last ethics approval

Tufts CSDD amendment study: Getz KA et al., Therapeutic Innovation & Regulatory Science, 2024; Applied Clinical Trials, December 2023.

One system of record for your trial spend

Clinical trial budget management next to your CTMS, ERP and payment provider. Not replacing your systems. Orchestrating them.

From site contract to month-end accruals

Site budgets with versions and an awarded version, priced from your own benchmarks, with CRO and vendor budgets beside them; every invoice recorded against them, flagged when off budget, with month-end accruals.

From the site contract to invoices to month-end accruals
Scenario panel with the enrollment slider above spend projection by quarter

An enrollment change, priced in the meeting

Scenario planning prices more patients, a delay or one more site in seconds; spend projection turns it into R&D spend by quarter for the business plan and latest estimates.

A Decision Cockpit for the R&D portfolio

Every study shows its forecast at end, burn vs. progress and health status with alerts; leadership compares business units and cost per patient, with unlimited read-only viewers.

Study cockpit cards with burn-down beside the business-unit comparison

One system of record for your trial spend

Clinical trial budget management next to your CTMS, ERP and payment provider. Not replacing your systems. Orchestrating them.

From site contract to month-end accruals

Site budgets with versions and an awarded version, priced from your own benchmarks, with CRO and vendor budgets beside them; every invoice recorded against them, flagged when off budget, with month-end accruals.

From the site contract to invoices to month-end accruals
Scenario panel with the enrollment slider above spend projection by quarter

An enrollment change, priced in the meeting

Scenario planning prices more patients, a delay or one more site in seconds; spend projection turns it into R&D spend by quarter for the business plan and latest estimates.

A Decision Cockpit for the R&D portfolio

Every study shows its forecast at end, burn vs. progress and health status with alerts; leadership compares business units and cost per patient, with unlimited read-only viewers.

Study cockpit cards with burn-down beside the business-unit comparison

One system of record for your trial spend

Clinical trial budget management next to your CTMS, ERP and payment provider. Not replacing your systems. Orchestrating them.

From site contract to month-end accruals

Site budgets with versions and an awarded version, priced from your own benchmarks, with CRO and vendor budgets beside them; every invoice recorded against them, flagged when off budget, with month-end accruals.

From the site contract to invoices to month-end accruals
Scenario panel with the enrollment slider above spend projection by quarter

An enrollment change, priced in the meeting

Scenario planning prices more patients, a delay or one more site in seconds; spend projection turns it into R&D spend by quarter for the business plan and latest estimates.

A Decision Cockpit for the R&D portfolio

Every study shows its forecast at end, burn vs. progress and health status with alerts; leadership compares business units and cost per patient, with unlimited read-only viewers.

Study cockpit cards with burn-down beside the business-unit comparison

Ready for R&D finance, procurement and IT

The answers a biopharma review asks for, before the first study goes live.

Business Units, One Instance

Several business units in one instance, separated by roles and compared in reports.

Single Sign-On

Entra ID, Okta or Google via OpenID Connect, plus MFA and IP allow-listing.

Germany, EU or US

Hosted where your setup requires, encrypted in transit and at rest.

Rollout to Your Scope

Self-service study setup; migration, training and hypercare as your scope needs.

Audit-Ready

Every change and every export logged; GDPR-compliant, with 21 CFR Part 11 readiness.

Your Data, Your Exit

Complete CSV export at any time; DPA, SLA and exit clause in the agreement.

Ready for R&D finance, procurement and IT

The answers a biopharma review asks for, before the first study goes live.

Business Units, One Instance

Several business units in one instance, separated by roles and compared in reports.

Single Sign-On

Entra ID, Okta or Google via OpenID Connect, plus MFA and IP allow-listing.

Germany, EU or US

Hosted where your setup requires, encrypted in transit and at rest.

Rollout to Your Scope

Self-service study setup; migration, training and hypercare as your scope needs.

Audit-Ready

Every change and every export logged; GDPR-compliant, with 21 CFR Part 11 readiness.

Your Data, Your Exit

Complete CSV export at any time; DPA, SLA and exit clause in the agreement.

Ready for R&D finance, procurement and IT

The answers a biopharma review asks for, before the first study goes live.

Business Units, One Instance

Several business units in one instance, separated by roles and compared in reports.

Single Sign-On

Entra ID, Okta or Google via OpenID Connect, plus MFA and IP allow-listing.

Germany, EU or US

Hosted where your setup requires, encrypted in transit and at rest.

Rollout to Your Scope

Self-service study setup; migration, training and hypercare as your scope needs.

Audit-Ready

Every change and every export logged; GDPR-compliant, with 21 CFR Part 11 readiness.

Your Data, Your Exit

Complete CSV export at any time; DPA, SLA and exit clause in the agreement.

Questions from biopharma R&D teams

Short answers for clinical operations, R&D finance, procurement and IT.

  • What is clinical trial financial management?

    Planning, tracking and forecasting what a clinical trial costs: site budgets, invoices, accruals and forecasts in one system. The Sponsor Suite does this for biopharma R&D, for pharma and biotech sponsors alike, next to your CTMS, ERP and payment provider.

  • Does it cover site budgets and investigator grants?

  • Who uses the Sponsor Suite?

  • Can R&D finance plan R&D spend with it?

  • Can several business units share one instance?

  • How long does a rollout take?

Questions from biopharma R&D teams

Short answers for clinical operations, R&D finance, procurement and IT.

  • What is clinical trial financial management?

    Planning, tracking and forecasting what a clinical trial costs: site budgets, invoices, accruals and forecasts in one system. The Sponsor Suite does this for biopharma R&D, for pharma and biotech sponsors alike, next to your CTMS, ERP and payment provider.

  • Does it cover site budgets and investigator grants?

  • Who uses the Sponsor Suite?

  • Can R&D finance plan R&D spend with it?

  • Can several business units share one instance?

  • How long does a rollout take?

Questions from biopharma R&D teams

Short answers for clinical operations, R&D finance, procurement and IT.

  • What is clinical trial financial management?

    Planning, tracking and forecasting what a clinical trial costs: site budgets, invoices, accruals and forecasts in one system. The Sponsor Suite does this for biopharma R&D, for pharma and biotech sponsors alike, next to your CTMS, ERP and payment provider.

  • Does it cover site budgets and investigator grants?

  • Who uses the Sponsor Suite?

  • Can R&D finance plan R&D spend with it?

  • Can several business units share one instance?

  • How long does a rollout take?

Bring one site budget and one question

Start with a 30-minute call about your trials — the demo that follows builds a site budget, records an invoice and prices your open scenario.

Bring one site budget and one question

Start with a 30-minute call about your trials — the demo that follows builds a site budget, records an invoice and prices your open scenario.

Bring one site budget and one question

Start with a 30-minute call about your trials — the demo that follows builds a site budget, records an invoice and prices your open scenario.